File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

TitleRamucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Authors
Issue Date2015
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetoncol
Citation
The Lancet Oncology, 2015, v. 16 n. 7, p. 859-870 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/217268
ISSN
2015 Impact Factor: 26.509
2015 SCImago Journal Rankings: 13.940

 

DC FieldValueLanguage
dc.contributor.authorZhu, AX-
dc.contributor.authorPark, JO-
dc.contributor.authorRyoo, BY-
dc.contributor.authorYen, CJ-
dc.contributor.authorPoon, RTP-
dc.date.accessioned2015-09-18T05:54:30Z-
dc.date.available2015-09-18T05:54:30Z-
dc.date.issued2015-
dc.identifier.citationThe Lancet Oncology, 2015, v. 16 n. 7, p. 859-870-
dc.identifier.issn1470-2045-
dc.identifier.urihttp://hdl.handle.net/10722/217268-
dc.languageeng-
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetoncol-
dc.relation.ispartofThe Lancet Oncology-
dc.titleRamucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial-
dc.typeArticle-
dc.identifier.emailPoon, RTP: poontp@hku.hk-
dc.identifier.authorityPoon, RTP=rp00446-
dc.identifier.doi10.1016/S1470-2045(15)00050-9-
dc.identifier.pmid26095784-
dc.identifier.hkuros254801-
dc.identifier.volume16-
dc.identifier.issue7-
dc.identifier.spage859-
dc.identifier.epage870-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats